The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes
主要な著者: | Mohanlal, N, Holman, R |
---|---|
フォーマット: | Conference item |
出版事項: |
2002
|
類似資料
-
Nateglinide, but not repaglinide, stimulates growth hormone secretion from rat pituitary cells.
著者:: Bokvist, K, 等
出版事項: (2000) -
Effect of nateglinide on the incidence of diabetes and cardiovascular events.
著者:: Holman, R, 等
出版事項: (2010) -
A review of nateglinide in the management of patients with type 2 diabetes
著者:: Nicholas Tentolouris, 等
出版事項: (2008-01-01) -
Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166).
著者:: Gribble, F, 等
出版事項: (2001) -
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
著者:: Califf, R, 等
出版事項: (2008)